William C. Roberts
Investor Relations Contact at G1 THERAPEUTICS, INC.
William C. Roberts active positions
| Companies | Position | Start | End |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Contact | 03/01/2021 | - |
| Public Communications Contact | 03/01/2021 | - |
Career history of William C. Roberts
Former positions of William C. Roberts
| Companies | Position | Start | End |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Investor Relations Contact | - | 22/10/2017 |
| Viropharma, Inc. | Public Communications Contact | - | - |
| ZYNERBA PHARMACEUTICALS, INC. | Investor Relations Contact | 30/04/2017 | - |
| Public Communications Contact | 30/04/2017 | - | |
| Medimmune, Inc. | Investor Relations Contact | - | - |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Investor Relations Contact | - | - |
| Public Communications Contact | 16/06/2010 | - |
Training of William C. Roberts
| University of Virginia | Undergraduate Degree |
| Keller Graduate School of Management | Masters Business Admin |
Statistics
International
| United States | 8 |
| United Kingdom | 2 |
Operational
| Investor Relations Contact | 5 |
| Public Communications Contact | 4 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
| Medimmune, Inc. | Health Technology |
| Viropharma, Inc. |
- Stock Market
- Insiders
- William C. Roberts
- Experience